China: Qiming leads $20M series A in Connect Biopharmaceuticals to advance clinical study

China: Qiming leads $20M series A in Connect Biopharmaceuticals to advance clinical study

Juliet Shwe Gaung

26 January, 2017

CBP-201 CBP-307 Connect Biopharma Connect Biopharmaceuticals Ltd Cowin Venture Capital Lapam Capital Northern Light Venture Capital Qiming Venture Partners

Printed by Unregistered user on Sun, 28 Dec 2025 15:25:39 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

Policy & Regulations

China to require repatriation of funds raised overseas under new rules

Policy & Regulations

China issues draft rules to govern AI with human-like interaction